Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引：0
|
作者：
B Ghanim
M A Hoda
T Klikovits
M-P Winter
A Alimohammadi
M Grusch
B Dome
M Arns
P Schenk
M Jakopovic
M Samarzija
L Brcic
M Filipits
V Laszlo
W Klepetko
W Berger
B Hegedus
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery
[2] Institute of Cancer Research,Department of Internal Medicine I
[3] Medical University of Vienna,Department of Thoracic Surgery
[4] National Koranyi Institute of Pulmonology,Department of Pulmonology
[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac
[6] LKH Hochegg,Department of Biological Physics
[7] University of Zagreb,undefined
[8] School of Medicine,undefined
[9] University Hospital Center,undefined
[10] University of Zagreb,undefined
[11] School of Medicine,undefined
[12] Institute of Pathology,undefined
[13] Eötvös University,undefined
[14] MTA-SE Molecular Oncology Research Group,undefined
[15] Hungarian Academy of Sciences,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：984 / 990
页数：6
相关论文
共 50 条
  • [41] Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy
    Akgun, Hakan
    Metintas, Selma
    Ak, Guntulu
    Demirkol, Secil
    Aydin, Resat
    Isbilen, Murat
    Gure, Ali
    Metintas, Muzaffer
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1369 - S1369
  • [42] A new prognostic score in patients with malignant pleural mesothelioma
    Selvaggi, G.
    Bille, A.
    Gisabella, M.
    Righi, L.
    Errico, L.
    Borasio, P.
    Ardissone, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Prognostic Factors for 100 Patients With Malignant Pleural Mesothelioma
    Gonlugur, Ugur
    Gonlugur, Tanseli Efeoglu
    ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, 2010, 65 (02) : 65 - 69
  • [44] Prognostic role of osteopontin expression in malignant pleural mesothelioma
    Cappia, Susanna
    Righi, Luisella
    Mirabelli, Dario
    Ceppi, Paolo
    Bacillo, Elisa
    Ardissone, Francesco
    Molinaro, Luca
    Scagliotti, Giorgio V.
    Papotti, Mauro
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (01) : 58 - 64
  • [45] PLEURAL FLUID ANALYSIS IN MALIGNANT MESOTHELIOMA - PROGNOSTIC IMPLICATIONS
    GOTTEHRER, A
    TARYLE, DA
    REED, CE
    SAHN, SA
    CHEST, 1991, 100 (04) : 1003 - 1006
  • [46] Clinical and biologic prognostic factors in malignant pleural mesothelioma
    Ambrogi, Vincenzo
    Mineo, Tommaso Claudio
    THORACIC CANCER, 2012, 3 (04) : 289 - 302
  • [47] Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Study
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Kobayashi, Masashi
    Okamoto, Norio
    Matsuura, Yuka
    Tamiya, Motohiro
    Morishita, Naoko
    Okafuji, Kohei
    Shiroyama, Takayuki
    Morimura, Osamu
    Morita, Satomu
    Kawase, Ichiro
    INTERNAL MEDICINE, 2012, 51 (07) : 707 - 710
  • [48] Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
    Zhou, Jian-Guo
    Zhong, Hua
    Zhang, Juan
    Jin, Su-Han
    Roudi, Raheleh
    Ma, Hu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [49] Prognostic factors in malignant pleural mesothelioma: A multicentric study
    Baptista, M. M.
    Barata, J.
    Fernandes, G.
    Saleiro, S.
    Souto Moura, M.
    Magalhaes, A.
    Valente, M. J.
    Valente, M. L. S. B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S806 - S807
  • [50] Inflammatory Biomarkers as Prognostic Factors for Malignant Pleural Mesothelioma
    Yerigeri, K.
    Morrow, B.
    Steinberg, S. M.
    Sengupta, M.
    Hassan, R.
    Puthiamadathil, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S388 - S388
12345